Novartis Australia Privacy and PS Collection Statement
By providing your personal information to Novartis Pharmaceuticals Australia Pty Ltd or its related bodies corporate (Novartis), you consent to Novartis collecting, storing and using your personal information in accordance with the Novartis Privacy Policy. In particular, you consent to Novartis using your personal information to communicate with you about Novartis products and/or to support your use of those products, and you consent to Novartis using your personal information for audit or inspection purposes. Novartis reserves the right to use aggregated and de-identified data collected through this Activity. You also consent to Novartis using your personal information to (where applicable) invite you to, or arrange your participation in, activities managed by (or on behalf of) Novartis.
Novartis has engaged third party service providers (Cube Pty Ltd.) for the purposes of collecting user contacts details and following up with users at a later date. Approved Contractors, for the purposes of the Activity, may include Bonnie Leibel, Nicole Birch, or Kayla Behayi. You consent to the Approved Contractor(s) collecting, storing and using your personal information in connection with the Activity, including to organise your participation in the Activity or to communicate with you in relation to the Activity, in accordance with the Novartis Privacy Policy.
Novartis is committed to patient safety. In accordance with regulatory obligations for reporting safety information Novartis processes reports of adverse events experienced by patients on Novartis products when identified by a Novartis representative (or by a third party acting on behalf of Novartis). Novartis Patient Safety may contact you or your healthcare professional in order to collect further information on the adverse event. This information may be shared with health authorities or other pharmaceutical companies with whom Novartis has a license agreement, and third parties we work with for the purpose of safety reporting.
You are not obliged to provide personal information. However, if you do not provide information you may not, for example, be able to participate fully in activities managed by us.
You have the right to access, update or correct your personal information and/or decline to receive communications from Novartis. To find out how, please refer to our Privacy Policy or contact our Privacy Officer at Novartis Australia, 54 Waterloo Road Macquarie Park NSW 2113. Phone: 02 9805 3555 Email: [email protected].
Novartis Pharmaceuticals Australia Pty Limited. ABN 18 004 244 160. 54 Waterloo Road, Macquarie Park, NSW 2113. MM2021 AU-17007 DOP June 2021